Global Urinary Tract Infection Treatment Industry was US$ 9.96 Billion in 2021
The increased prevalence of urinary tract infections and the rise in the number of hospital visits for urinary tract infection testing and treatment predict that the urinary tract infection treatment market will grow significantly. Furthermore, the rising demand for antibiotics in the treatment of urinary tract infections and the increase in the number of generic players are also expected to propel the urinary tract infection treatment market forward.
COVID-19 Impact on the Urinary Tract Infection Treatment Industry:
The unusual increase in coronavirus-infected patients led to limited access to other primary care services was hampered, and non-COVID-19-related diagnoses such as urinary tract infection dropped significantly. As per the analysis, in 2020, the weekly rate of UTI diagnoses decreased somewhat, slowing the industry's expansion 2020. However, as the market is recovering, the rate of UTI diagnosis has increased over time; the market's growth has been favorably enhanced. The rising preponderance of diabetes and kidney stones and the introduction of combination medications are driving market expansion.
The Quinolones Segment Leads the Global Urinary Tract Infection Treatment Market:
By Types, Quinolones, B-lactam Cephalosporins, Aminoglycosides, Penicillin, and Azoles are among the categories included in this report. According to the estimates, the quinolones category will dominate the global urinary tract infection treatment market. Many doctors advise their patients to promptly take quinolones to get rid of their infection. Moreover, the quinolones sector is expected to increase at the fastest CAGR during the projected period. According to the analysis, Urinary Tract Infection Treatment Market Size set to grow by 2.26% during 2021-2027.
In the Urinary Tract Infection Treatment Industry, the Complicated UTIs Segment Holds a Major Share:
We have analyzed the market for uncomplicated and complicated UTIs based on disease type. According to the research, the urinary tract infection therapy market is dominated by Complicated UTIs. Furthermore, due to the rise in drug-resistant bacteria and overuse of antibiotics, the prevalence of complicated UTIs is predicted to rise in the future. Most doctors prescribe quinolones to treat complex UTI situations. Cephalosporin is the second-most-prescribed antibiotic for complex UTIs.
Regional Realms in Urinary Tract Infection Treatment Industry:
Our research covers the regional markets for America, Europe, Asia Pacific, the Middle East, and Africa. During the study period, America and Europe held a significant market share in the global urinary tract infection treatment market, according to the analysis. However, developing regions such as Asia-Pacific and the Middle East and Africa (MEA) are growing the urinary tract infection treatment market due to rising government initiatives for healthcare spending and increased knowledge about urinary tract infection treatment.
Key Players:
Novartis AG, Allergan, Bayer HealthCare Pharmaceuticals, AstraZeneca, GlaxoSmithKline PLC, Pfizer, Merck & Co., Inc, and Bristol-Myers Squibb Company are amongst the leading competitors in the urinary tract infection treatment industry. Further, to drive their company portfolio across the worldwide market, these organizations employ various techniques, including innovative product releases and R&D.
The publisher's latest report Urinary Tract Infection Treatment Market, Global Forecast By Type (Quinolones, B-lactam Cephalosporins, Aminoglycosides, Penicillin, Azoles and Others), Disease Type (Uncomplicated UTI, Complicated UTI and Others), Region (America, Europe, Asia Pacific and MEA), Companies (Novartis AG, Allergan, Bayer HealthCare Pharmaceuticals, AstraZeneca, GlaxoSmithKline PLC, Pfizer, Merck & Co., Inc, and Bristol-Myers Squibb Company)” provides a detailed analysis of Urinary Tract Infection Treatment Industry.
Type - Market has been covered from 6 viewpoints:
1. Quinolones
2. B-lactam Cephalosporins
3. Aminoglycosides
4. Penicillin
5. Azoles
6. Others
Disease Type - Market has been covered from 3 viewpoints:
1. Uncomplicated UTI
2. Complicated UTI
3. Others
Region - Market has been covered from 4 viewpoints:
1. America
2. Europe
3. Asia Pacific
4. Middle East & Africa
Company Insights:
- Company Profile
- Recent Developments
- Revenue
Companies Covered:
1. Novartis AG
2. Allergan
3. Bayer HealthCare Pharmaceuticals
4. Astrazeneca
5. GlaxoSmithKline PLC
6. Pfizer
7. Merck & Co., Inc
8. Bristol-Myers Squibb Company
What is the estimated value of the Global Urinary Tract Infection Treatment Market?
What is the growth rate of the Global Urinary Tract Infection Treatment Market?
What is the forecasted size of the Global Urinary Tract Infection Treatment Market?
Who are the key companies in the Global Urinary Tract Infection Treatment Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 115 |
| Published | April 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 9.96 Billion |
| Forecasted Market Value ( USD | $ 11.39 Billion |
| Compound Annual Growth Rate | 2.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
Table of Contents
Companies Mentioned
- Novartis AG
- Allergan
- Bayer HealthCare Pharmaceuticals
- Astrazeneca
- GlaxoSmithKline PLC
- Pfizer
- Merck & Co., Inc
- Bristol-Myers Squibb Company
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
